857 - Process Development and Manufacturing: A CLINICAL-GRADE MANUFACTURING PROCESS USING CLINIMACS PRODIGY® FOR CAR-NK CELL-BASED IMMUNOTHERAPY
| Autor: | Kuska, J., Müller, S., Sohmen, M., Kostyra, J., Mekes, A., Raasch, J., Lange, K., Janz, E., Meinersen, L., Mues, M., Möker, N. |
|---|---|
| Zdroj: | In Cytotherapy May 2023 25(6) Supplement:S191-S191 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect